InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by VEDANTA PARTNERS, LLC. Director active across 1 companies, notably Reviva Pharmaceuticals Holdings, INC.. Aggregated, 2 reports have been published. Total volume traded: €5.7m. The latest transaction was filed on 1 June 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
€3m931,000 shares@ €3.0693100.0% of flow
Common Stock
SEC:0001062993-21-005353·
Ideal exit: 26 Feb 2022 (T+270)
€3m931,000 shares@ €3.06938.77% mcap50.0% of flow
Common Stock
SEC:0001062993-21-005353:0·
Ideal exit: 26 Feb 2022 (T+270)
2 of 2 declarations
